| Literature DB >> 29282756 |
Rebecca L Tamez1, Whitney V Tan2, John T O'Malley3, Karen R Broder4, Maria C Garzon2,5, Philip LaRussa5, Christine T Lauren2,5.
Abstract
A 2-year-old boy with influenza B infection and rapidly worsening targetoid skin lesions with mucosal involvement was diagnosed with Stevens-Johnson syndrome (SJS) and treated with oseltamivir and intravenous immunoglobulin, with resolution of illness. Subsequent quadrivalent inactivated influenza vaccine was well tolerated. This case highlights the rarity of SJS in the setting of influenza B infection and addresses the safety of administering subsequent influenza vaccines to such individuals.Entities:
Keywords: influenza vaccine; intravenous immunoglobulin; vaccine safety
Mesh:
Substances:
Year: 2017 PMID: 29282756 PMCID: PMC6628912 DOI: 10.1111/pde.13370
Source DB: PubMed Journal: Pediatr Dermatol ISSN: 0736-8046 Impact factor: 1.588